Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages

@article{Wang2010Fra1PR,
  title={Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages},
  author={Qingshan Wang and Hong Ni and Lan Lan and Xiaoli Wei and Rong Xiang and Yue Wang},
  journal={Cell Research},
  year={2010},
  volume={20},
  pages={701-712}
}
The tumor microenvironment (TME) plays a prominent role in the growth of tumor cells. As the major inflammatory component of the TME, M2d macrophages are educated by the TME such that they adopt an immunosuppressive role that promotes tumor metastasis and progression. Fra-1 forms activator protein-1 heterodimers with Jun partners and drives gene transcription. Fra-1 is thought to drastically induce tumorigenesis and progression. However, the functional role of Fra-1 in the generation of M2d… 

M-CSF cooperating with NFκB induces macrophage transformation from M1 to M2 by upregulating c-Jun

M-CSF induces macrophage transformation by upregulating c-Jun with a certain synergy of NFκB, and may present a novel therapeutic strategy against cancer.

PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism

The results suggest that the activation of PTEN and NHERF-1 may impede the evolution of macrophages beyond the M1 into M2 phenotype in tumor microenvironment.

MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene

Findings indicate that miR-19a-3p is capable of downregulating the M2 phenotype in M2 macrophages and that the low expression of this miRNA has an important role in the upregulation of Fra-1 expression and induction of M2macrophage polarization.

Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2

Cancer cells recruit monocytes, macrophages and other inflammatory cells by producing abundant chemoattractants and growth factors, such as macrophage colony-stimulating factor (M-CSF/CSF-1) and

Regulation of tumor-associated macrophage (TAM) differentiation by NDRG2 expression in breast cancer cells

The results suggest that NDRG2 expression in breast cancer may reduce the differentiation of macrophages into TAMs in the TME.

Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis.

It is suggested that Fra-1 orchestrates the inflammatory state of macrophages by inhibition of Arg1 expression and thereby impedes the resolution of inflammation.

MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response

Recent findings in miRNA expression profiles in polarized macrophages from murine and human sources are highlighted, and how these miRNAs regulate macrophage polarization is summarized.

Macrophages in Tumor-Associated Adipose Microenvironment Accelerate Tumor Progression.

The results demonstrate that the niche factors in TAME, such as exosomal miRNA-155, regulate the function and polarity of macrophages to facilitate tumor progression.

Inhibition of TGF-β induced lipid droplets switches M2 macrophages to M1 phenotype.

Activating THP1-derived macrophage in vitro

In this chapter, the methods to generate different phenotypes of activated macrophages by adding certain stimuli are described and the distinct markers and/or cytokines used to verification of each activated Macrophages are summarized.
...

References

SHOWING 1-10 OF 47 REFERENCES

FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo.

It is suggested that FRA-1 can promote motility, invasion, and anchorage-independent growth of lung epithelial cells in vitro, but is insufficient for tumor formation.

Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.

It is demonstrated that the autocrine production of IL-6 by tumor cells promotes resistance of the cells to chemotherapy, a novel function ofIL-6 in cancer biology.

FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells

Results show that high Fra-1 expression is associated with a more malignant cell phenotype and suggest thatFra-1 could have a pivotal role in breast cancer progression, and directly induced M MP-1 and MMP-9 promoter activity.

Macrophage activation and polarization.

The main functions of polarized macrophages are reviewed and the perspectives of this field are discussed, which include high endocytic clearance capacities and trophic factor synthesis, accompanied by reduced pro-inflammatory cytokine secretion.

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.

A new tumor-escape mechanism associated with TAM generation via LIF and IL-6 is revealed and these findings offer novel therapeutic perspectives to subvert TAM-induced immunosuppression and hence improve T-cell-based antitumor immunotherapy efficacy.

Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma

Data show that aaMphi play a critical role in tumor‐induced lymphangiogenesis through up‐regulating VEGF‐C and increasing lymphang iogenesis‐related behavior of LECs, which may contribute to lymphatic invasion in lung adenocarcinoma.

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.

The data suggest that VEGF, at pathologically relevant concentrations in vivo, may exert effects on pluripotent stem cells that result in blocked DC development as well as affect many other hematopoietic lineages.

The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.

IL-6 is implicate as a possible factor important in breast cancer progression and metastasis formation, although the clinical significance of this cytokine in Breast cancer patients could not be established.

IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation1

IL-6 is a potent regulator of DC differentiation in vivo, and IL-6-gp130-STAT3 signaling in DCs may represent a critical target for controlling T cell-mediated immune responses in vivo.